Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
ALDX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

6.19

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

-0.01

EPS Last/This Y

0.26

EPS This/Next Y

0.08

Price

1.55

Target Price

6.6

Analyst Recom

1.4

Performance Q

-10.4

Upside

-1,138.7%

Beta

1.2

Ticker: ALDX



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13ALDX1.920.130.1410200
2026-07-14ALDX1.940.153.1210732
2026-07-15ALDX1.930.153.8610793
2026-07-16ALDX1.720.1834.9711355
2026-07-17ALDX1.670.190.7011468
2026-07-20ALDX1.70.180.0010295
2026-07-21ALDX1.7550.180.0010690
2026-07-22ALDX1.7050.170.9111019
2026-07-23ALDX1.550.170.1011022
2026-07-24ALDX1.5250.162.0210958
2026-07-27ALDX1.580.200.1110686
2026-07-28ALDX1.590.200.3610840
2026-07-29ALDX1.6150.190.6210852
2026-07-30ALDX1.610.200.1710889
2026-07-31ALDX1.5450.160.2310650
2026-08-03ALDX1.5250.080.089796
2026-08-04ALDX1.5450.080.079890
2026-08-05ALDX1.6050.080.0410212
2026-08-06ALDX1.5950.084.8610305
2026-08-07ALDX1.550.080.0610325
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13ALDX1.9251.6- -0.30
2026-07-14ALDX1.9451.6- -0.30
2026-07-15ALDX1.9351.6- -0.30
2026-07-16ALDX1.7251.6- -0.30
2026-07-17ALDX1.6751.6- -0.30
2026-07-20ALDX1.7051.6- -0.30
2026-07-21ALDX1.7651.6- -0.30
2026-07-22ALDX1.7051.6- -0.30
2026-07-23ALDX1.5551.6- -0.30
2026-07-24ALDX1.5251.6- -0.30
2026-07-27ALDX1.5751.6- -0.30
2026-07-28ALDX1.5951.6- -0.30
2026-07-29ALDX1.6251.6- -0.30
2026-07-30ALDX1.6051.6- -0.30
2026-07-31ALDX1.5451.6- -0.30
2026-08-03ALDX1.5251.6- -0.30
2026-08-04ALDX1.5251.6- -0.30
2026-08-05ALDX1.6051.6- -0.30
2026-08-06ALDX1.5951.6- -0.30
2026-08-07ALDX1.5551.6- -0.30
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13ALDX17.04-7.469.77
2026-07-14ALDX17.04-7.469.77
2026-07-15ALDX17.04-7.469.77
2026-07-16ALDX17.04-7.469.77
2026-07-17ALDX17.04-7.469.77
2026-07-20ALDX17.04-6.719.77
2026-07-21ALDX17.04-6.719.77
2026-07-22ALDX17.04-6.719.77
2026-07-23ALDX17.04-6.719.77
2026-07-24ALDX17.04-6.719.77
2026-07-27ALDX17.04-6.686.19
2026-07-28ALDX17.04-6.686.19
2026-07-29ALDX17.04-6.686.19
2026-07-30ALDX17.04-6.686.19
2026-07-31ALDX17.04-6.686.19
2026-08-03ALDX17.04-10.946.19
2026-08-04ALDX17.04-10.946.19
2026-08-05ALDX17.04-10.946.19
2026-08-06ALDX17.04-10.946.19
2026-08-07ALDX17.04-10.946.19
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-0.06

Avg. EPS Est. Current Quarter

-0.08

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

17.04

Institutional Transactions

-10.94

Beta

1.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

11

Growth Score

22

Sentiment Score

13

Actual DrawDown %

87.1

Max Drawdown 5-Year %

-89.6

Target Price

6.6

P/E

Forward P/E

PEG

P/S

P/B

2.22

P/Free Cash Flow

EPS

-0.46

Average EPS Est. Cur. Y​

-0.3

EPS Next Y. (Est.)

-0.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.87

Return on Equity vs Sector %

-92.2

Return on Equity vs Industry %

-76.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ ALDX Healthcare
$1.55
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
4/20
Pullback
23/25
Volume
7/15
Valuation
12/20
TP/AR
2/10
Options
7/10
RSI
39.4
Range 1M
12%
Sup Dist
0.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
33 /100
WEAK
Momentum
2/25
Growth
21/30
Estimates
0/20
Inst/Vol
0/15
Options
10/10
EPS Yr
42.4%
EPS NY
20.9%
52W%
9.9%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +325.8% upside
Quality
2/30
Valuation
16/30
Growth
18/25
Stability
7/10
LT Trend
1/5
Upside
+325.8%
Quality
11
Click a card to see score breakdown Full Analysis →
ALDX — P/E HistoricalBiotechnology
Aldeyra Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 8
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
ALDX

Latest News

—
Caricamento notizie per ALDX…
stock quote shares ALDX – Aldeyra Therapeutics, Inc. Stock Price stock today
news today ALDX – Aldeyra Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALDX – Aldeyra Therapeutics, Inc. yahoo finance google finance
stock history ALDX – Aldeyra Therapeutics, Inc. invest stock market
stock prices ALDX premarket after hours
ticker ALDX fair value insiders trading